F11 and deep vein thrombosis: Notably, this variant was identified in an individual with high FXI levels from the GAIT-2 Project, so the new putative pathogenic mutation NM_001102416.2: c.758-12T>C in the KNG1 was genotyped in the case-control study of thrombosis.